Intra-erythrocyte deposition of growth hormone in rheumatic diseases

Rheumatology International

Volumn 23, Issue 1, 2003, Pages 11-14

  Denko, Charles W ^a   Boja, Betty ^a   Malemud, Charles J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Research Institute   (United States)

Author keywords

Erythrocyte; Growth hormone; Human; Rheumatic diseases; Serum

Indexed keywords

GROWTH HORMONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GOUT; GROWTH HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPEROSTOSIS; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RHEUMATIC DISEASE; SJOEGREN SYNDROME;

EID: 0037283240     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-002-0245-4     Document Type: Article

References (19)

1. 'Franchimont P, Denis F (1968) Determination de taux de somatotrophines darts cas d'arthrose apparaissant lors de menopause. J Belge Rheumatol Med Phys 23:59-64
2. 'Denko C (1979) Restorative chemotherapy in degenerative hip disease. Agents Actions 8:268-279
3. 'Dequeker J, Burssens A, Bouillon R (1982) Dynamics of growth hormone secretion in patients with osteoarthritis. Hormone Res 16:353-356
4. 'Denko CW, Boja B, Moskowitz RW (1990) Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor, growth hormone. J Rheumatol 17:1217-1221
5. 'Denko CW, Boja B (1993) Growth factors in asymptomatic osteoarthritis - insulin, insulin-like growth factor-1, growth hormone. Inflammopharmacology 3:71-76
6. 'Denko CW, Boja B, Moskowitz RW (1996) Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic diseases. Osteoarthritis Cartilage 4:245-249
7. 'Denko CW, Boja B, Moskowitz RW (1994) Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis-insulin, insulin-like growth factor-1, growth hormone. J Rheumatol 21:1725-1730
8. 'Denko CW, Boja B, Malemud CJ (2002) Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci 7:a37-a43
9. 'Denko CW, Boja B (2001) Growth hormone, insulin-like growth factor-1 in hypermobility syndrome. J Rheumatol 28:1666-1669
10. Denko CW, Malemud CJ (1999) Metabolic disturbances and synovial fluid responses in osteoarthritis. Front Biosci 4:d686-d693
11. Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pelletier J-P (1998) IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 47:90-100
12. Klippel J (1997) Primer on the rheumatic diseases, 11th edn. The Arthritis Foundation, Atlanta
13. Keligman M (1991) Age-related alterations of growth hormone/insulin-like growth factor-I axis. J Am Geriatr Soc 39:295-307
14. Ojeda SR, McCann SM (2000) Textbook of endocrine physiology. Oxford University Press, Oxford
15. Sandulyak LI (1976) Erythrocytes as depot and transport system of hormones. Dopovidi Akad Nauk Ukrainskoi RSR Series B:61-63
16. Matuliavichius V, Vareikis EI, Lashas LV (1986) Insulin-like substance and insulin-degrading complex of hemolysates of human erythrocytes. Biokhimiia 51:276-284
17. Sonnenberg M (1971) Interaction of human growth hormone and human erythrocyte membranes studied by intrinsic fluorescence. Proc Natl Acad Sci U S A 68:1051-1055
18. Postel-Vinay M-C, Sonnenberg M, Swislocki NI (1974) Effect of growth hormone on rat liver plasma membranes as studied by circular dichroism and fluorescence using the extrinsic probe 7,12 dimethylbenzanthracene. Biochim Biophys Acta 332:156-165
19. Attur MG, Dave M, Akamatsu M, Katoh M, Amin R (2002) Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 10:1-4